Athena was named Medical winner for this year's James Dyson Award The Athena wearable uses scalp cooling to reduce hair loss in chemotherapy patients ... recognising the best inventions by student ...

LumiThera Inc., a medical device company offering photobiomodulation (PBM) treatment for ocular damage and disease, today announced the U.S. Food & Drug Administration (FDA) has authorized marketing ...

Three patients in the UK have received a"groundbreaking" treatment for lupus on the NHS, which experts hope could eradicate ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

Sometimes, it’s all about incorporating more nutrient-rich foods into your diet. Other times, adding a few workouts to your ...

ZORYVE cream 0.15% is the first once-daily, Food and Drug Administration ... INDICATION ZORYVE cream, 0.15%, is indicated for topical treatment of mild to moderate atopic dermatitis in adult and ...

For chronic myeloid leukemia (CML) patients, there is a promising new first-line drug approval with asciminib (brand name ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

Bristol Myers Squibb on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended expanded approval of its Augtyro cancer drug in a pair of indications.